Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 122-96-3 | MDL No. : | MFCD00006157 |
Formula : | C8H18N2O2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | VARKIGWTYBUWNT-UHFFFAOYSA-N |
M.W : | 174.24 | Pubchem ID : | 67151 |
Synonyms : |
|
Num. heavy atoms : | 12 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 1.0 |
Num. rotatable bonds : | 4 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 54.4 |
TPSA : | 46.94 Ų |
GI absorption : | Low |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -8.28 cm/s |
Log Po/w (iLOGP) : | 1.83 |
Log Po/w (XLOGP3) : | -1.29 |
Log Po/w (WLOGP) : | -2.17 |
Log Po/w (MLOGP) : | -0.83 |
Log Po/w (SILICOS-IT) : | -0.24 |
Consensus Log Po/w : | -0.54 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | 0.16 |
Solubility : | 250.0 mg/ml ; 1.43 mol/l |
Class : | Highly soluble |
Log S (Ali) : | 0.8 |
Solubility : | 1100.0 mg/ml ; 6.33 mol/l |
Class : | Highly soluble |
Log S (SILICOS-IT) : | -0.13 |
Solubility : | 130.0 mg/ml ; 0.746 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.65 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
79% | at 180 - 200℃; for 10 h; Autoclave; Inert atmosphere | Example 2Preparation of 1,4-bis(hydroxyethyl)piperazine from diethanolamine (no solvent)Example 2 was carried out under the conditions of example 1 in the same apparatus. 100 g of diethanolamine (II) and 10 g of catalyst A were used. Gas chromatographic analysis (GC column: 30 m RTX Amin) indicated, at quantitative diethanolamine conversion, that the reaction output comprised 79percent of 1,4-bis(hydroxyethyl)piperazine. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
86.2% | With hydrogenchloride In methanol; water for 2.5 h; Inert atmosphere | Under a nitrogen atmosphere, the reactor 100 ml, piperazine 8.6 g (0.1 mol) g of methanol 10.4 g, was added while stirring 35percent hydrochloric acid 10.4 g (0.1 mol), internal temperature It was referred to as 80 ° C. There, while maintaining the internal temperature below 80 ° C, 2- bromoethanol 8.7g of (0.07 mol) was added dropwise over 0.5 hours and then further continued for 2 hours and stirring remains the same temperature conditions. Since the reaction liquid was 4.2 where pH was measured, and added of 25percent NaOH aqueous solution 7.6 g, and the pH was adjusted to 8.5. Furthermore, maintaining the internal temperature at 80 ° C, stirring was continued for 2 hours to obtain a reaction solution 36.2g of colorless and transparent. Results The product was analyzed by gas chromatography, is 86.2percent for a yield of N-(2-hydroxyethyl) piperazine, the selectivity, N-(2-hydroxyethyl) piperazine, 91.9percent, N, N'- bis (2-hydroxyethyl) piperazine is 6.7percent, unknown content was 1.4percent. Along with other examples showing the results of Example 8 shown in Table 1. |
[ 111-41-1 ]
N-(2-Hydroxyethyl)ethylenediamine
Similarity: 0.83
[ 13349-82-1 ]
2-(2-(Piperazin-1-yl)ethoxy)ethanol
Similarity: 0.78
[ 5317-33-9 ]
3-(4-Methylpiperazin-1-yl)propan-1-ol
Similarity: 0.73
[ 3445-00-9 ]
2-(4-(3-Chloropropyl)piperazin-1-yl)ethanol dihydrochloride
Similarity: 0.69
[ 13349-82-1 ]
2-(2-(Piperazin-1-yl)ethoxy)ethanol
Similarity: 0.78
[ 108302-54-1 ]
N-Ethyl-2-morpholinoethanamine
Similarity: 0.74
[ 5317-33-9 ]
3-(4-Methylpiperazin-1-yl)propan-1-ol
Similarity: 0.73
[ 934-98-5 ]
2-(4-Methylpiperazin-1-yl)ethanamine
Similarity: 0.72
[ 54699-92-2 ]
4-Methyl-1-piperazineacetic acid
Similarity: 0.72
[ 13349-82-1 ]
2-(2-(Piperazin-1-yl)ethoxy)ethanol
Similarity: 0.78
[ 5317-33-9 ]
3-(4-Methylpiperazin-1-yl)propan-1-ol
Similarity: 0.73
[ 934-98-5 ]
2-(4-Methylpiperazin-1-yl)ethanamine
Similarity: 0.72